196 related articles for article (PubMed ID: 26323836)
1. In Vitro Infectivity Assessment by Drug Susceptibility Comparison of Recombinant Leishmania major Expressing Enhanced Green Fluorescent Protein or EGFP-Luciferase Fused Genes with Wild-Type Parasite.
Sadeghi S; Seyed N; Etemadzadeh MH; Abediankenari S; Rafati S; Taheri T
Korean J Parasitol; 2015 Aug; 53(4):385-94. PubMed ID: 26323836
[TBL] [Abstract][Full Text] [Related]
2. Generation of stable L. major(+EGFP-LUC) and simultaneous comparison between EGFP and luciferase sensitivity.
Taheri T; Saberi Nik H; Seyed N; Doustdari F; Etemadzadeh MH; Torkashvand F; Rafati S
Exp Parasitol; 2015 Mar; 150():44-55. PubMed ID: 25637784
[TBL] [Abstract][Full Text] [Related]
3. EGFP reporter protein: its immunogenicity in Leishmania-infected BALB/c mice.
Seif S; Kazemi F; Gholami E; Seyed N; Taslimi Y; Habibzadeh S; Azarian B; Jamshidi S; Hashemi M; Rafati S; Taheri T
Appl Microbiol Biotechnol; 2016 May; 100(9):3923-34. PubMed ID: 26685673
[TBL] [Abstract][Full Text] [Related]
4. Use of Optical Imaging Technology in the Validation of a New, Rapid, Cost-Effective Drug Screen as Part of a Tiered
Caridha D; Parriot S; Hudson TH; Lang T; Ngundam F; Leed S; Sena J; Harris M; O'Neil M; Sciotti R; Read L; Lecoeur H; Hickman M; Grogl M
Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28137819
[TBL] [Abstract][Full Text] [Related]
5. Parasite burden in Leishmania (Leishmania) amazonensis-infected mice: validation of luciferase as a quantitative tool.
Reimão JQ; Trinconi CT; Yokoyama-Yasunaka JK; Miguel DC; Kalil SP; Uliana SR
J Microbiol Methods; 2013 May; 93(2):95-101. PubMed ID: 23466934
[TBL] [Abstract][Full Text] [Related]
6. Appraisal of a Leishmania major strain stably expressing mCherry fluorescent protein for both in vitro and in vivo studies of potential drugs and vaccine against cutaneous leishmaniasis.
Calvo-Álvarez E; Guerrero NA; Alvarez-Velilla R; Prada CF; Requena JM; Punzón C; Llamas MÁ; Arévalo FJ; Rivas L; Fresno M; Pérez-Pertejo Y; Balaña-Fouce R; Reguera RM
PLoS Negl Trop Dis; 2012; 6(11):e1927. PubMed ID: 23209866
[TBL] [Abstract][Full Text] [Related]
7. Transgenic Leishmania donovani clinical isolates expressing green fluorescent protein constitutively for rapid and reliable ex vivo drug screening.
Singh N; Gupta R; Jaiswal AK; Sundar S; Dube A
J Antimicrob Chemother; 2009 Aug; 64(2):370-4. PubMed ID: 19525291
[TBL] [Abstract][Full Text] [Related]
8. Episomal and stable expression of the luciferase reporter gene for quantifying Leishmania spp. infections in macrophages and in animal models.
Roy G; Dumas C; Sereno D; Wu Y; Singh AK; Tremblay MJ; Ouellette M; Olivier M; Papadopoulou B
Mol Biochem Parasitol; 2000 Oct; 110(2):195-206. PubMed ID: 11071276
[TBL] [Abstract][Full Text] [Related]
9. Improvement of the green fluorescent protein reporter system in Leishmania spp. for the in vitro and in vivo screening of antileishmanial drugs.
Pulido SA; Muñoz DL; Restrepo AM; Mesa CV; Alzate JF; Vélez ID; Robledo SM
Acta Trop; 2012 Apr; 122(1):36-45. PubMed ID: 22155571
[TBL] [Abstract][Full Text] [Related]
10. Generation and Characterization of a Dual-Reporter Transgenic
Sharma R; Silveira-Mattos PS; Ferreira VC; Rangel FA; Oliveira LB; Celes FS; Viana SM; Wilson ME; de Oliveira CI
Front Cell Infect Microbiol; 2019; 9():468. PubMed ID: 32039047
[TBL] [Abstract][Full Text] [Related]
11. Achievement of constitutive fluorescent pLEXSY-egfp Leishmania braziliensis and its application as an alternative method for drug screening in vitro.
Bastos MS; Souza LÂ; Onofre TS; Silva A; Almeida MR; Bressan GC; Fietto JL
Mem Inst Oswaldo Cruz; 2017 Feb; 112(2):155-159. PubMed ID: 28177050
[TBL] [Abstract][Full Text] [Related]
12. Studies in vitro on infectivity and sensitivity to antileishmanial drugs in New World Leishmania species transfected with the green fluorescent protein [pIR3(-)-eGFP].
Palacios G; Parodi A; Upegui YA; Montoya A; Pulido S; Vélez ID; Robledo SM
Parasitology; 2017 Nov; 144(13):1718-1725. PubMed ID: 28831945
[TBL] [Abstract][Full Text] [Related]
13. In Vivo Bioluminescent Monitoring of Parasites in BALB/c Mouse Models of Cutaneous Leishmaniasis Drug Discovery.
Caridha D; Leed S; Cawlfield A
Methods Mol Biol; 2020; 2081():81-106. PubMed ID: 31721120
[TBL] [Abstract][Full Text] [Related]
14. An alternative in vitro drug screening test using Leishmania amazonensis transfected with red fluorescent protein.
Rocha MN; Corrêa CM; Melo MN; Beverley SM; Martins-Filho OA; Madureira AP; Soares RP
Diagn Microbiol Infect Dis; 2013 Mar; 75(3):282-91. PubMed ID: 23312610
[TBL] [Abstract][Full Text] [Related]
15. Development of NanoLuc-PEST expressing Leishmania mexicana as a new drug discovery tool for axenic- and intramacrophage-based assays.
Berry SL; Hameed H; Thomason A; Maciej-Hulme ML; Saif Abou-Akkada S; Horrocks P; Price HP
PLoS Negl Trop Dis; 2018 Jul; 12(7):e0006639. PubMed ID: 30001317
[TBL] [Abstract][Full Text] [Related]
16. A new chimeric triple reporter fusion protein as a tool for in vitro and in vivo multimodal imaging to monitor the development of African trypanosomes and Leishmania parasites.
Calvo-Alvarez E; Cren-Travaillé C; Crouzols A; Rotureau B
Infect Genet Evol; 2018 Sep; 63():391-403. PubMed ID: 29339220
[TBL] [Abstract][Full Text] [Related]
17. Neolignan Licarin A presents effect against Leishmania (Leishmania) major associated with immunomodulation in vitro.
Néris PL; Caldas JP; Rodrigues YK; Amorim FM; Leite JA; Rodrigues-Mascarenhas S; Barbosa-Filho JM; Rodrigues LC; Oliveira MR
Exp Parasitol; 2013 Oct; 135(2):307-13. PubMed ID: 23891943
[TBL] [Abstract][Full Text] [Related]
18. DNA Integration in Leishmania Genome: An Application for Vaccine Development and Drug Screening.
Taheri T; Seyed N; Rafati S
Methods Mol Biol; 2016; 1403():603-22. PubMed ID: 27076156
[TBL] [Abstract][Full Text] [Related]
19. Fluorescent Leishmania species: development of stable GFP expression and its application for in vitro and in vivo studies.
Bolhassani A; Taheri T; Taslimi Y; Zamanilui S; Zahedifard F; Seyed N; Torkashvand F; Vaziri B; Rafati S
Exp Parasitol; 2011 Mar; 127(3):637-45. PubMed ID: 21187086
[TBL] [Abstract][Full Text] [Related]
20. Intracellular parasite kill: flow cytometry and NO detection for rapid discrimination between anti-leishmanial activity and macrophage activation.
Kram D; Thäle C; Kolodziej H; Kiderlen AF
J Immunol Methods; 2008 Apr; 333(1-2):79-88. PubMed ID: 18313691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
